JP2014524747A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524747A5
JP2014524747A5 JP2014520591A JP2014520591A JP2014524747A5 JP 2014524747 A5 JP2014524747 A5 JP 2014524747A5 JP 2014520591 A JP2014520591 A JP 2014520591A JP 2014520591 A JP2014520591 A JP 2014520591A JP 2014524747 A5 JP2014524747 A5 JP 2014524747A5
Authority
JP
Japan
Prior art keywords
concentration
factor
collection
detergent
ctab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014520591A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524747A (ja
JP6275641B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/063045 external-priority patent/WO2013010797A1/en
Publication of JP2014524747A publication Critical patent/JP2014524747A/ja
Publication of JP2014524747A5 publication Critical patent/JP2014524747A5/ja
Application granted granted Critical
Publication of JP6275641B2 publication Critical patent/JP6275641B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014520591A 2011-07-20 2012-07-04 ウイルス抗原およびワクチンの製造方法 Expired - Fee Related JP6275641B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161509630P 2011-07-20 2011-07-20
US61/509,630 2011-07-20
EP11174660.8 2011-07-20
EP11174660 2011-07-20
PCT/EP2012/063045 WO2013010797A1 (en) 2011-07-20 2012-07-04 Process for producing viral antigen and vaccines

Publications (3)

Publication Number Publication Date
JP2014524747A JP2014524747A (ja) 2014-09-25
JP2014524747A5 true JP2014524747A5 (enExample) 2016-11-04
JP6275641B2 JP6275641B2 (ja) 2018-02-07

Family

ID=45094875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520591A Expired - Fee Related JP6275641B2 (ja) 2011-07-20 2012-07-04 ウイルス抗原およびワクチンの製造方法

Country Status (12)

Country Link
EP (1) EP2734619B1 (enExample)
JP (1) JP6275641B2 (enExample)
KR (2) KR20140038530A (enExample)
CN (1) CN103827296B (enExample)
AU (1) AU2012286098C1 (enExample)
BR (1) BR112014001049A2 (enExample)
CA (1) CA2841604C (enExample)
ES (1) ES2653197T3 (enExample)
MX (1) MX2014000753A (enExample)
RU (1) RU2565827C2 (enExample)
TW (1) TW201311896A (enExample)
WO (1) WO2013010797A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109568573A (zh) * 2014-12-12 2019-04-05 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
SG11202004725PA (en) 2017-12-19 2020-07-29 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
JP7360594B2 (ja) * 2017-12-28 2023-10-13 共立製薬株式会社 ワクチン製剤、並びに魚類のイリドウイルス感染症予防方法
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
KR102714626B1 (ko) 2018-06-12 2024-10-08 케이바이오 홀딩스 리미티드 바이러스 및 항원 정제 및 접합
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
JP2021528999A (ja) * 2018-07-04 2021-10-28 プロバイオジェン アーゲー エンベロープウイルスの精製方法
JP7518825B2 (ja) 2018-11-15 2024-07-18 バイエル・ヘルスケア・エルエルシー 抗体の連続的製造のためのウイルス不活化方法
RU2710239C1 (ru) * 2019-06-14 2019-12-25 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
EP4054630A2 (en) * 2019-11-07 2022-09-14 Seqirus UK Limited Compositions and methods for producing a viral vaccine with reduced particle size
KR102546626B1 (ko) * 2020-04-29 2023-06-21 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
EP4144753A4 (en) * 2020-04-29 2024-12-25 SK Bioscience Co., Ltd. Influenza virus production method using disposable culture process system, and test for quickly checking conditions for influenza virus antigen purification
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4240762A (en) * 1979-03-12 1980-12-23 Johnston Pump Company Seal-aligning rigid coupling assembly
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
EP1597400B8 (en) * 2003-02-25 2013-10-09 MedImmune, LLC Methods of producing influenza vaccine compositions
RU2283139C1 (ru) * 2005-03-21 2006-09-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения антигенов для вакцины против вирусов гриппа
EP1982727A1 (en) * 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
WO2009029695A1 (en) * 2007-08-28 2009-03-05 Baxter International Inc. Method for producing viral vaccines
US20110014230A1 (en) * 2008-03-18 2011-01-20 Novartis Ag preparation of influenza virus vaccine antigens
AU2009296628B2 (en) * 2008-09-24 2015-01-15 Medimmune, Llc Methods for purification of viruses
US8202726B2 (en) * 2008-09-24 2012-06-19 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process

Similar Documents

Publication Publication Date Title
JP2014524747A5 (enExample)
JP5745717B2 (ja) ウイルス精製のための連続超遠心分離用の糖溶液の処方
EP0199698B1 (fr) Procédé d'extraction et de purification de protéines issues de milieux de culture les produisant
Weigel et al. A flow-through chromatography process for influenza A and B virus purification
JP6720288B2 (ja) ウイルス用無菌精製プロセス
Rupar et al. Fast purification of the filamentous Potato virus Y using monolithic chromatographic supports
JP2017523035A5 (enExample)
Wang et al. Exosomes released from rabies virus-infected cells may be involved in the infection process
CN102286460A (zh) 一种改进ctab法提取杏鲍菇中的dna
US11697800B2 (en) Method for the separation of virus compositions including depletion and purification thereof
CN104531642A (zh) 以Gemini表面活性剂反胶束从菠萝皮中萃取分离菠萝蛋白酶的方法
CN108611327B (zh) 一种猪圆环病毒2型病毒样颗粒的分离纯化方法
KR101942626B1 (ko) 노다바이러스 캡시드 단백질의 정제 수율 증가 방법
CN107164334B (zh) 一种猪圆环病毒繁殖培养基及其应用
JP6467139B2 (ja) 狂犬病ウイルスの複製促進・増強方法
CN102757474B (zh) 一种去除蛋白制备过程中所使用离液剂的方法
Wang et al. A primary study on partial purification of lysozyme from chicken egg white using foam separation method
CN120192936A (zh) 一种高剂量流感病毒裂解疫苗原液的制备方法
JP2025092571A (ja) 低減した粒度を有するウイルスワクチンを生成するための組成物および方法
CN104130317B (zh) 一种重组戊型肝炎疫苗p179抗原的纯化方法
HK1138318B (en) Formulation of sugar solutions for continuous ultracentrifugation for virus purification